Kronos Worldwide Inc 10-Q for FY2021 Q2
Kronos Worldwide Inc (KRO)
About this 10-Q
Kronos Worldwide Inc filed this 10-Q on August 4, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).
Headline figures
Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $478.6M
- up 24.0% from $386M a year earlier
- Net income
- $25.7M
- up 38.2% from net income of $18.6M a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
OR
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction of incorporation or organization) |
|
(IRS Employer Identification No.) |
(Address of principal executive offices)
Registrant’s telephone number, including area code: (
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
☐ |
|
☒ |
|
|
Non-accelerated filer |
☐ |
Smaller reporting company |
|
|
|
Emerging growth company |
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
Number of shares of the registrant’s common stock, $.01 par value per share, outstanding on July 30, 2021:
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES
INDEX
|
|
|
|
|
Page |
|
|
Part I. |
|
FINANCIAL INFORMATION |
|
|
|
|
Item 1. |
|
Financial Statements |
|
|
|
|
|
|
Condensed Consolidated Balance Sheets - |
|
3 |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
8 |
|
|
|
|
Notes to Condensed Consolidated Financial Statements (unaudited) |
|
9 |
|
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
16 |
|
|
Item 3. |
|
|
|
25 |
|
|
Item 4. |
|
|
|
26 |
|
|
Part II. |
|
|
|
||
|
Item 1. |
|
|
27 |
||
|
Item 1A. |
|
|
|
27 |
|
|
Item 6. |
|
|
|
27 |
|
|
Items 2, 3, 4 and 5 of Part II are omitted because there is no information to report. |
|
|
|||
- 2 -
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions)
|
|
December 31, |
|
|
June 30, |
|
||
|
|
2020 |
|
|
2021 |
|
||
|
|
|
|
|
|
(unaudited) |
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
|
|
|
$ |
|
|
|
Restricted cash |
|
|
|
|
|
|
|
|
Accounts and other receivables, net |
|
|
|
|
|
|
|
|
Inventories, net |
|
|
|
|
|
|
|
|
Prepaid expenses and other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets: |
|
|
|
|
|
|
|
|
Investment in TiO2 manufacturing joint venture |
|
|
|
|
|
|
|
|
Restricted cash |
|
|
|
|
|
|
|
|
Marketable securities |
|
|
|
|
|
|
|
|
Operating lease right-of-use assets |
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment: |
|
|
|
|
|
|
|
|
Land |
|
|
|
|
|
|
|
|
Buildings |
|
|
|
|
|
|
|
|
Equipment |
|
|
|
|
|
|
|
|
Mining properties |
|
|
|
|
|
|
|
|
Construction in progress |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less accumulated depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net property and equipment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
$ |
|
|
|
$ |
|
|
- 3 -
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)
(In millions)
|
|
December 31, |
|
|
June 30, |
|
||
|
|
2020 |
|
|
2021 |
|
||
|
|
|
|
|
|
(unaudited) |
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Current maturities of long-term debt |
$ |
|
|
|
$ |
|
|
|
Accounts payable and accrued liabilities |
|
|
|
|
|
|
|
|
Income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Noncurrent liabilities: |
|
|
|
|
|
|
|
|
Long-term debt |
|
|
|
|
|
|
|
|
Accrued pension costs |
|
|
|
|
|
|
|
|
Payable to affiliate - income taxes |
|
|
|
|
|
|
|
|
Operating lease liabilities |
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total noncurrent liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Common stock |
|
|
|
|
|
|
|
|
Additional paid-in capital |
|
|
|
|
|
|
|
|
Retained deficit |
|
( |
) |
|
|
( |
) |
|
Accumulated other comprehensive loss |
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
Total stockholders' equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity |
$ |
|
|
|
$ |
|
|
Commitments and contingencies (Notes 10 and 12)
See accompanying notes to Condensed Consolidated Financial Statements.
- 4 -
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In millions, except per share data)
|
|
Three months ended |
|
|
Six months ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
||||
|
|
(unaudited) |
|
|||||||||||||
|
Net sales |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
Cost of sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other operating income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency transactions, net |
|
( |
) |
|
|
|
|
|
|
|
|
|
|
- |
|
|
Other operating expense, net |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and dividend income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance settlement gain |
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
Marketable equity securities |
|
( |
) |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
Other components of net periodic pension and OPEB cost |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Interest expense |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per basic and diluted share |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in the calculation of net income per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to Condensed Consolidated Financial Statements.
- 5 -
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
|
|
Three months ended |
|
|
Six months ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
||||
|
|
(unaudited) |
|
|||||||||||||
|
Net income |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss), net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency translation |
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
Defined benefit pension plans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other postretirement benefit plans |
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss), net |
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
See accompanying notes to Condensed Consolidated Financial Statements.
- 6 -
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In millions)
|
|
Three months ended June 30, 2020 and 2021 (unaudited) |
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
|
other |
|
|
|
|
|
|
|
|
|
||
|
|
Common |
|
|
paid-in |
|
|
Retained |
|
|
comprehensive |
|
|
Treasury |
|
|
|
|
|
|||||
|
|
stock |
|
|
capital |
|
|
deficit |
|
|
loss |
|
|
stock |
|
|
Total |
|
||||||
|
|
|
|
|||||||||||||||||||||
|
Balance at March 31, 2020 |
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
|
Net income |
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
Issuance of common stock |
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Dividends paid - $ |
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
Treasury stock retired |
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 30, 2020 |
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
- |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2021 |
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
- |
|
|
$ |
|
|
|
Net income |
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
Issuance of common stock |
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Dividends paid - $ |
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 30, 2021 |
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
- |
|
|
$ |
|
|
|
|
Six months ended June 30, 2020 and 2021 (unaudited) |
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
|
other |
|
|
|
|
|
|
|
|
|
||
|
|
Common |
|
|
paid-in |
|
|
Retained |
|
|
comprehensive |
|
|
Treasury |
|
|
|
|
|
|||||
|
|
stock |
|
|
capital |
|
|
deficit |
|
|
loss |
|
|
stock |
|
|
Total |
|
||||||
|
|
|
|
|||||||||||||||||||||
|
Balance at December 31, 2019 |
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
- |
|
|
$ |
|
|
|
Net income |
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Other comprehensive loss, net of tax |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
( |
) |
|
Issuance of common stock |
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Dividends paid - $ |
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
Treasury stock acquired |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
( |
) |
|
Treasury stock retired |
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 30, 2020 |
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
- |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2020 |
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
- |
|
|
$ |
|
|
|
Net income |
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
Issuance of common stock |
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Dividends paid - $ |
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 30, 2021 |
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
- |
|
|
$ |
|
|
See accompanying notes to Condensed Consolidated Financial Statements.
- 7 -
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
|
|
Six months ended |
|
|||||
|
|
June 30, |
|
|||||
|
|
2020 |
|
|
2021 |
|
||
|
|
(unaudited) |
|
|||||
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income |
$ |
|
|
|
$ |
|
|
|
Depreciation |
|
|
|
|
|
|
|
|
Amortization of operating lease right-of-use assets |
|
|
|
|
|
|
|
|
Deferred income taxes |
|
( |
) |
|
|
|
|
|
Benefit plan expense greater than cash funding |
|
|
|
|
|
|
|
|
Marketable equity securities |
|
|
|
|
|
( |
) |
|
Contributions to TiO2 manufacturing joint venture, net |
|
( |
) |
|
|
( |
) |
|
Other, net |
|
( |
) |
|
|
|
|
|
Change in assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts and other receivables, net |
|
( |
) |
|
|
( |
) |
|
Inventories, net |
|
( |
) |
|
|
|
|
|
Prepaid expenses |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
( |
) |
|
|
( |
) |
|
Income taxes |
|
|
|
|
|
( |
) |
|
Accounts with affiliates |
|
( |
) |
|
|
( |
) |
|
Other, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Capital expenditures |
|
( |
) |
|
|
( |
) |
|
Proceeds from insurance settlement |
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Payments on long-term debt |
|
( |
) |
|
|
( |
) |
|
Deferred financing fees |
|
- |
|
|
|
( |
) |
|
Dividends paid |
|
( |
) |
|
|
( |
) |
|
Treasury stock acquired |
|
( |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities |
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash - net change from: |
|
|
|
|
|
|
|
|
Operating, investing and financing activities |
|
( |
) |
|
|
|
|
|
Currency translation |
|
( |
) |
|
|
( |
) |
|
Balance at beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at end of period |
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures: |
|
|
|
|
|
|
|
|
Cash paid for: |
|
|
|
|
|
|
|
|
Interest, net of amount capitalized |
$ |
|
|
|
$ |
|
|
|
Income taxes |
|
|
|
|
|
|
|
|
Accrual for capital expenditures |
|
|
|
|
|
|
|
See accompanying notes to Condensed Consolidated Financial Statements.
- 8 -
KRONOS WORLDWIDE, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2021
(unaudited)
Note 1 - Organization and basis of presentation:
Organization - At June 30, 2021, Valhi, Inc. (NYSE: VHI) held approximately
Basis of presentation - The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2020 that we filed with the Securities and Exchange Commission (SEC) on March 10, 2021 (2020 Annual Report). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments), in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2020 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2020) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). Our results of operations for the interim periods ended June 30, 2021 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2020 Consolidated Financial Statements contained in our 2020 Annual Report.
Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and its subsidiaries (NYSE: KRO) taken as a whole.
Note 2 - Accounts and other receivables, net:
|
|
December 31, |
|
|
June 30, |
|
||
|
|
2020 |
|
|
2021 |
|
||
|
|
(In millions) |
|
|||||
|
Trade receivables |
$ |
|
|
|
$ |
|
|
|
Recoverable VAT and other receivables |
|
|
|
|
|
|
|
|
Receivables from affiliates |
|
|
|
|
|
|
|
|
Refundable income taxes |
|
|
|
|
|
|
|
|
Allowance for doubtful accounts |
|
( |
) |
|
|
( |
) |
|
Total |
$ |
|
|
|
$ |
|
|
- 9 -
Note 3 - Inventories, net:
|
|
December 31, |
|
|
June 30, |
|
||
|
|
2020 |
|
|
2021 |
|
||
|
|
(In millions) |
|
|||||
|
Raw materials |
$ |
|
|
|
$ |
|
|
|
Work in process |
|
|
|
|
|
|
|
|
Finished products |
|
|
|
|
|
|
|
|
Supplies |
|
|
|
|
|
|
|
|
Total |
$ |
|
|
|
$ |
|
|
Note 4 - Marketable securities:
Our marketable securities consist of investments in the publicly-traded shares of related parties: Valhi, NL and CompX International Inc. NL owns the majority of CompX’s outstanding common stock.
|
|
|
Fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
measurement |
|
Market |
|
|
Cost |
|
|
Unrealized |
|
|||
|
Marketable security |
|
level |
|
value |
|
|
basis |
|
|
gain (loss) |
|
|||
|
|
|
|
|
(In millions) |
|
|||||||||
|
December 31, 2020: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valhi common stock |
|
1 |
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
NL and CompX common stocks |
|
1 |
|
|
|
|
|
|
|
|
|
|
- |
|
|
Total |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2021: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valhi common stock |
|
1 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
NL and CompX common stocks |
|
1 |
|
|
|
|
|
|
|
|
|
|
- |
|
|
Total |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
At December 31, 2020 and June 30, 2021, we held approximately
The Valhi, CompX and NL common stocks we own are subject to restrictions on resale pursuant to certain provisions of SEC Rule 144. In addition, as a majority-owned subsidiary of Valhi we cannot vote our shares of Valhi common stock under Delaware General Corporation law, but we receive dividends from Valhi on these shares when declared and paid.
Note 5 - Long-term debt:
|
|
December 31, |
|
|
June 30, |
|
||
|
|
2020 |
|
|
2021 |
|
||
|
|
(In millions) |
|
|||||
|
Kronos International, Inc. 3.75% Senior Notes |
$ |
|
|
|
$ |
|
|
|
Other |
|
|
|
|
|
|
|
|
Total debt |
|
|
|
|
|
|
|
|
Less current maturities |
|
|
|
|
|
|
|
|
Total long-term debt |
$ |
|
|
|
$ |
|
|
Senior Notes - At June 30, 2021, the carrying value of our
Revolving credit facilities - On April 20, 2021, we entered into a new global $
- 10 -
full $
Other - We are in compliance with all of our debt covenants at June 30, 2021.
Note 6 - Accounts payable and accrued liabilities:
|
|
December 31, |
|
|
June 30, |
|
||
|
|
2020 |
|
|
2021 |
|
||
|
|
(In millions) |
|
|||||
|
Accounts payable |
$ |
|
|
|
$ |
|
|
|
Employee benefits |
|
|
|
|
|
|
|
|
Accrued sales discounts and rebates |
|
|
|
|
|
|
|
|
Payables to affiliates: |
|
|
|
|
|
|
|
|
Louisiana Pigment Company, L.P. |
|
|
|
|
|
|
|
|
Income taxes payable to Valhi |
|
|
|
|
|
|
|
|
Operating lease liabilities |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Total |
$ |
|
|
|
$ |
|
|
Note 7 - Other noncurrent liabilities:
|
|
December 31, |
|
|
June 30, |
|
||
|
|
2020 |
|
|
2021 |
|
||
|
|
(In millions) |
|
|||||
|
Accrued postretirement benefits |
$ |
|
|
|
$ |
|
|
|
Employee benefits |
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
Total |
$ |
|
|
|
$ |
|
|
- 11 -
Note 8 - Revenue recognition:
The following table disaggregates our net sales by place of manufacture (point of origin) and to the location of the customer (point of destination), which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.
|
|
Three months ended |
|
|
Six months ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
||||
|
|
(In millions) |
|
|||||||||||||
|
Net sales - point of origin: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
Germany |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norway |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Eliminations |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Total |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales - point of destination: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
North America |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Note 9 - Employee benefit plans:
|
|
Three months ended |
|
|
Six months ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
||||
|
|
(In millions) |
|
|||||||||||||
|
Service cost |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
Interest cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected return on plan assets |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Amortization of prior service cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognized actuarial losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
- 12 -
We expect our 2021 contributions for our pension plans to be approximately $
Note 10 - Income taxes:
|
|
Three months ended |
|
|
Six months ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
||||
|
|
(In millions) |
|
|||||||||||||
|
Expected tax expense, at U.S. federal statutory income tax rate of |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
Non-U.S. tax rates |
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Incremental net tax benefit on earnings and losses of U.S. and non-U.S. companies |
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Global intangible low-tax income, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation allowance, net |
|
|
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
Adjustment to the reserve for uncertain tax positions, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
Nondeductible expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other, net |
|
( |
) |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
Income tax expense |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive provision for income taxes allocable to: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension plans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPEB plans |
|
( |
) |
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
Total |
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
The amount shown in the preceding table of our income tax rate reconciliation for non-U.S. tax rates represents the result determined by multiplying the pre-tax earnings or losses of each of our non-U.S. subsidiaries by the difference between the applicable statutory income tax rate for each non-U.S. jurisdiction and the U.S. federal statutory tax rate. The amount shown on such table for incremental net tax expense (benefit) on earnings and losses of U.S. and non-U.S. companies includes, as applicable, (i) deferred income taxes (or deferred income tax benefits) associated with the current-year earnings of all of our non-U.S. subsidiaries and (ii) current U.S. income taxes (or current income tax benefit) including U.S. personal holding company tax, as applicable, attributable to current-year income (losses) of one of our non-U.S. subsidiaries, which subsidiary is treated as a dual resident for U.S. income tax purposes, to the extent the current-year income (losses) of such subsidiaries is subject to U.S. income tax under the U.S. dual-resident provisions of the Internal Revenue Code.
On March 27, 2020, the “Coronavirus Aid, Relief and Economic Security (CARES) Act” was signed into law in response to the COVID-19 pandemic. The CARES Act, among other things, includes modifications to the limitation of business interest for tax years beginning in 2019 and 2020 increasing the business interest limitation from
Tax authorities are examining certain of our U.S. and non-U.S. tax returns and may propose tax deficiencies, including penalties and interest. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity. We currently estimate that our unrecognized tax benefits will decrease by approximately $
- 13 -
Note 11 – Accumulated other comprehensive loss:
Changes in accumulated other comprehensive loss are presented in the table below. See Note 4 for further discussion of our marketable securities and Note 9 for discussion of our defined benefit pension plans.
|
|
Three months ended |
|
|
Six months ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
||||
|
|
(In millions) |
|
|||||||||||||
|
Accumulated other comprehensive loss, net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency translation: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period |
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
Balance at end of period |
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defined benefit pension plans: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period |
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
Other comprehensive income - amortization of prior service cost and net losses included in net periodic pension cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at end of period |
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPEB plans: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period |
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
( |
) |
|
Other comprehensive loss - amortization of prior service credit and net losses included in net periodic OPEB cost |
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
( |
) |
|
Balance at end of period |
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total accumulated other comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period |
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
Balance at end of period |
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Note 12 - Commitments and contingencies:
Note 13 - Financial instruments:
See Note 4 for information on how we determine fair value of our marketable securities.
The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure:
|
|
|
December 31, 2020 |
|
|
June 30, 2021 |
|
||||||||||
|
|
|
Carrying amount |
|
|
Fair value |
|
|
Carrying amount |
|
|
Fair value |
|
||||
|
|
|
(In millions) |
|
|||||||||||||
|
Cash, cash equivalents and restricted cash |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
Long-term debt - Fixed rate Senior Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- 14 -
At June 30, 2021, the estimated market price of our Senior Notes was €
- 15 -
|
ITEM 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
RESULTS OF OPERATIONS
Business overview
We are a leading global producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used for a variety of manufacturing applications, including paints, plastics, paper and other industrial and specialty products. For the six months ended June 30, 2021, approximately one-half of our sales volumes were sold into European markets. Our production facilities are located in Europe and North America.
We consider TiO2 to be a “quality of life” product, with demand affected by gross domestic product, or GDP, and overall economic conditions in our markets located in various regions of the world. Over the long-term, we expect demand for TiO2 will grow by 2% to 3% per year, consistent with our expectations for the long-term growth in GDP. However, even if we and our competitors maintain consistent shares of the worldwide market, demand for TiO2 in any interim or annual period may not change in the same proportion as the change in GDP, in part due to relative changes in the TiO2 inventory levels of our customers. We believe our customers’ inventory levels are influenced in part by their expectation for future changes in TiO2 selling prices as well as their expectation for future availability of product. Although certain of our TiO2 grades are considered specialty pigments, the majority of our grades and substantially all of our production are considered commodity pigment products with price and availability being the most significant competitive factors along with product quality and customer and technical support services.
The factors having the most impact on our reported operating results are:
|
|
• |
TiO2 selling prices, |
|
|
• |
Our TiO2 sales and production volumes, |
|
|
• |
Manufacturing costs, particularly raw materials such as third-party feedstock, maintenance and energy-related expenses, and |
|
|
• |
Currency exchange rates (particularly the exchange rates for the U.S. dollar relative to the euro, the Norwegian krone and the Canadian dollar and the euro relative to the Norwegian krone). |
Our key performance indicators are our TiO2 average selling prices, our level of TiO2 sales and production volumes and the cost of our third-party feedstock. TiO2 selling prices generally follow industry trends and selling prices will increase or decrease generally as a result of competitive market pressures.
Executive summary
We reported net income of $25.7 million, or $.22 per share, in the second quarter of 2021 as compared to net income of $18.6 million, or $.16 per share, in the second quarter of 2020. For the first six months of 2021, we reported net income of $45.3 million, or $.39 per share, compared to net income of $45.6 million, or $.39 per share, in the first six months of 2020. We reported higher net income in the second quarter of 2021 as compared to the second quarter of 2020 primarily due to higher income from operations resulting from the effects of higher sales volumes and higher average TiO2 selling prices, partially offset by higher manufacturing and other production costs. Net income for the first six months of 2021 was comparable to net income for the first six months of 2020 as higher net sales resulting from higher sales volumes and higher average TiO2 selling prices were offset by higher manufacturing and other production costs. The second quarter of 2020 was the period most impacted by the COVID-19 pandemic, specifically through reduced demand for certain of our products. Comparability of our results was also impacted by the effects of changes in currency exchange rates.
- 16 -
Forward-looking information
This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements in this Quarterly Report on Form 10-Q that are not historical facts are forward-looking in nature and represent management’s beliefs and assumptions based on currently available information. Statements in this report including, but not limited to, statements found in Item 2 - “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” are forward-looking statements that represent our management’s beliefs and assumptions based on currently available information. In some cases you can identify forward-looking statements by the use of words such as “believes,” “intends,” “may,” “should,” “could,” “anticipates,” “expects” or comparable terminology, or by discussions of strategies or trends. Although we believe the expectations reflected in forward-looking statements are reasonable, we do not know if these expectations will be correct. Such statements by their nature involve substantial risks and uncertainties that could significantly impact expected results. Actual future results could differ materially from those predicted. The factors that could cause our actual future results to differ materially from those described herein are the risks and uncertainties discussed in this Quarterly Report and those described from time to time in our other filings with the SEC and include, but are not limited to, the following:
|
|
• |
Future supply and demand for our products |
|
|
• |
The extent of the dependence of certain of our businesses on certain market sectors |
|
|
• |
The cyclicality of our business |
|
|
• |
Customer and producer inventory levels |
|
|
• |
Unexpected or earlier-than-expected industry capacity expansion |
|
|
• |
Changes in raw material and other operating costs (such as energy and ore costs) |
|
|
• |
Changes in the availability of raw materials (such as ore) |
|
|
• |
General global economic and political conditions that harm the worldwide economy, disrupt our supply chain, increase material costs or reduce demand or perceived demand for our TiO2 products or impair our ability to operate our facilities (including changes in the level of gross domestic product in various regions of the world, natural disasters, terrorist acts, global conflicts and public health crises such as COVID-19) |
|
|
• |
Competitive products and substitute products |
|
|
• |
Customer and competitor strategies |
|
|
• |
Potential consolidation of our competitors |
|
|
• |
Potential consolidation of our customers |
|
|
• |
The impact of pricing and production decisions |
|
|
• |
Competitive technology positions |
|
|
• |
Potential difficulties in upgrading or implementing accounting and manufacturing software systems |
|
|
• |
The introduction of trade barriers or trade disputes |
|
|
• |
Fluctuations in currency exchange rates (such as changes in the exchange rate between the U.S. dollar and each of the euro, the Norwegian krone and the Canadian dollar and between the euro and the Norwegian krone), or possible disruptions to our business resulting from uncertainties associated with the euro or other currencies |
|
|
• |
Operating interruptions (including, but not limited to, labor disputes, leaks, natural disasters, fires, explosions, unscheduled or unplanned downtime, transportation interruptions, cyber-attacks and public health crises such as COVID-19) |
|
|
• |
Our ability to renew or refinance credit facilities |
|
|
• |
Our ability to maintain sufficient liquidity |
|
|
• |
The ultimate outcome of income tax audits, tax settlement initiatives or other tax matters, including future tax reform |
|
|
• |
Our ability to utilize income tax attributes, the benefits of which may or may not have been recognized under the more-likely-than-not recognition criteria |
|
|
• |
Environmental matters (such as those requiring compliance with emission and discharge standards for existing and new facilities) |
- 17 -
|
|
• |
Government laws and regulations and possible changes therein including new environmental health and safety regulations (such as those seeking to limit or classify TiO2 or its use) |
|
|
• |
Possible future litigation. |
Should one or more of these risks materialize (or the consequences of such a development worsen), or should the underlying assumptions prove incorrect, actual results could differ materially from those forecasted or expected. We disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of changes in information, future events or otherwise.
Results of operations
Current industry conditions
We started 2021 with average TiO2 selling prices 3% lower than at the beginning of 2020. Average TiO2 selling prices were 3% higher in the second quarter of 2021 as compared to the second quarter of 2020 and 1% higher in the first six months of 2021 as compared to the first six months of 2020. Our average TiO2 selling prices at the end of the second quarter of 2021 were 4% higher than the end of 2020. We experienced higher sales volumes in all major markets in the first six months of 2021 as compared to the same period of 2020 primarily due to the COVID-19 related demand contraction in 2020 which was most acute in the second quarter of 2020.
We operated our production facilities at overall average capacity utilization rates of 99% in the first six months of 2021 compared to 95% in the first six months of 2020. TiO2 production volumes were higher in the first six months of 2021 as compared to the first six months of 2020 due to higher anticipated demand and our corresponding adjustments to planned production levels in 2020 as a result of the COVID-19 pandemic. The table below lists our comparative quarterly production capacity utilization rates.
|
|
Production Capacity Utilization Rates |
|
|
|||
|
|
2020 |
|
|
2021 |
|
|
|
First quarter |
95% |
|
|
97% |
|
|
|
Second quarter |
96% |
|
|
100% |
|
|
Quarter ended June 30, 2021 compared to the quarter ended June 30, 2020
|
|
Three months ended June 30, |
|
||||||||||||||
|
|
2020 |
|
|
2021 |
|
|||||||||||
|
|
|
(Dollars in millions) |
|
|||||||||||||
|
Net sales |
$ |
386.0 |
|
|
|
100 |
% |
|
$ |
478.6 |
|
|
|
100 |
% |
|
|
Cost of sales |
|
290.2 |
|
|
|
75 |
|
|
|
369.6 |
|
|
|
77 |
|
|
|
Gross margin |
|
95.8 |
|
|
|
25 |
|
|
|
109.0 |
|
|
|
23 |
|
|
|
Selling, general and administrative expense |
|
52.7 |
|
|
|
13 |
|
|
|
62.9 |
|
|
|
13 |
|
|
|
Other operating income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency transactions, net |
|
(6.1 |
) |
|
|
(2 |
) |
|
|
.5 |
|
|
|
- |
|
|
|
Other operating expense, net |
|
(4.0 |
) |
|
|
(1 |
) |
|
|
(2.8 |
) |
|
|
(1 |
) |
|
|
Income from operations |
$ |
33.0 |
|
|
|
9 |
% |
|
$ |
43.8 |
|
|
|
9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Change |
|
|||||
|
TiO2 operating statistics: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales volumes* |
|
124 |
|
|
|
|
|
|
|
144 |
|
|
|
16 |
% |
|
|
Production volumes* |
|
133 |
|
|
|
|
|
|
|
137 |
|
|
|
2 |
% |
|
|
Percentage change in net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TiO2 sales volumes |
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
% |
|
|
TiO2 product pricing |
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
TiO2 product mix/other |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1 |
) |
|
|
Changes in currency exchange rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
24 |
% |
|
|
|
|
|
* |
Thousands of metric tons |
- 18 -
Net sales - Net sales in the second quarter of 2021 increased 24%, or $92.6 million, compared to the second quarter of 2020 primarily due to a 16% increase in sales volumes (which increased net sales by approximately $62 million), and a 3% increase in average TiO2 selling prices (which increased net sales by approximately $12 million). In addition to the impact of higher sales volumes and higher average selling prices, we estimate that changes in currency exchange rates (primarily the euro) increased our net sales by approximately $22 million in the second quarter of 2021 as compared to the second quarter of 2020. TiO2 selling prices will increase or decrease generally as a result of competitive market pressures, changes in the relative level of supply and demand as well as changes in raw material and other manufacturing costs.
Our sales volumes increased 16% in the second quarter of 2021 as compared to the second quarter of 2020 due to higher demand in all our major markets resulting from overall improvements in global economic activity in 2021 compared to the same period in 2020 when negative economic effects from the COVID-19 pandemic had the most significant impact.
Cost of sales and gross margin - Cost of sales increased $79.4 million, or 27%, in the second quarter of 2021 compared to the second quarter of 2020 due to a 16% increase in sales volumes and higher production costs of approximately $15 million (including higher costs for raw materials and energy). Our cost of sales as a percentage of net sales increased to 77% in the second quarter of 2021 compared to 75% in the same period of 2020 primarily due to the unfavorable effects of higher raw materials and other productions costs, as discussed above.
Gross margin as a percentage of net sales decreased to 23% in the second quarter of 2021 compared to 25% in the second quarter of 2020. As discussed and quantified above, our gross margin as a percentage of net sales decreased primarily due to the net effects of higher raw materials and other production costs partially offset by higher sales volumes and higher average TiO2 selling prices.
Selling, general and administrative expense - Selling, general and administrative expense was approximately 13% of net sales in the second quarters of 2021 and 2020.
Income from operations - Income from operations increased by $10.8 million, or 33%, in the second quarter of 2021 compared to the second quarter of 2020. Income from operations as a percentage of net sales was 9% in each of the second quarters of 2021 and 2020. Changes in currency exchange rates had a nominal effect on income from operations in the second quarter of 2021 as compared to the same period in 2020, as discussed below.
Other non-operating income (expense) - We recognized a gain of $.5 million on the change in value of our marketable equity securities in the second quarter of 2021 compared to a loss of $.2 million in the second quarter of 2020. See Note 4 to our Condensed Consolidated Financial Statements. Other components of net periodic pension and OPEB cost in the second quarter of 2021 was comparable to the second quarter of 2020. See Note 9 to our Condensed Consolidated Financial Statements. Interest expense in the second quarter of 2021 increased $.6 million compared to the second quarter of 2020 primarily due to costs associated with the refinancing of our revolving credit facility in April 2021. See Note 5 to our Condensed Consolidated Financial Statements.
Income tax expense - We recognized income tax expense of $9.2 million in the second quarter of 2021 compared to income tax expense of $5.1 million in the second quarter of 2020. The difference is primarily due to higher earnings in 2021 and the jurisdictional mix of earnings. Our earnings are subject to income tax in various U.S. and non-U.S. jurisdictions, and the income tax rates applicable to the pre-tax earnings (losses) of our non-U.S. operations are generally higher than the income tax rates applicable to our U.S. operations. We would generally expect our overall effective tax rate to be higher than the U.S. federal statutory tax rate of 21% primarily because of our sizeable non-U.S. operations. See Note 10 to our Condensed Consolidated Financial Statements.
- 19 -
Six months ended June 30, 2021 compared to the six months ended June 30, 2020
|
|
Six months ended June 30, |
|
||||||||||||||
|
|
2020 |
|
|
2021 |
|
|||||||||||
|
|
|
(Dollars in millions) |
|
|||||||||||||
|
Net sales |
$ |
807.0 |
|
|
|
100 |
% |
|
$ |
943.6 |
|
|
|
100 |
% |
|
|
Cost of sales |
|
623.1 |
|
|
|
77 |
|
|
|
738.9 |
|
|
|
78 |
|
|
|
Gross margin |
|
183.9 |
|
|
|
23 |
|
|
|
204.7 |
|
|
|
22 |
|
|
|
Selling, general and administrative expense |
|
106.2 |
|
|
|
13 |
|
|
|
120.9 |
|
|
|
13 |
|
|
|
Other operating income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency transactions, net |
|
6.1 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
Other operating expense, net |
|
(7.3 |
) |
|
|
(1 |
) |
|
|
(6.0 |
) |
|
|
(1 |
) |
|
|
Income from operations |
$ |
76.5 |
|
|
|
9 |
% |
|
$ |
77.8 |
|
|
|
8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Change |
|
|||||
|
TiO2 operating statistics: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales volumes* |
|
260 |
|
|
|
|
|
|
|
285 |
|
|
|
9 |
% |
|
|
Production volumes* |
|
265 |
|
|
|
|
|
|
|
267 |
|
|
|
1 |
% |
|
|
Percentage change in net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TiO2 sales volumes |
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
% |
|
|
TiO2 product pricing |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
TiO2 product mix/other |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
|
|
Changes in currency exchange rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
17 |
% |
|
|
|
|
* |
Thousands of metric tons |
Net sales - Net sales in the first six months of 2021 increased 17%, or $136.6 million, compared to the first six months of 2020 primarily due to a 9% increase in sales volumes (which increased net sales by approximately $73 million) and a 1% increase in average TiO2 selling prices (which increased net sales by approximately $8 million). In addition to the impact of higher sales volumes and higher average selling prices, we estimate that changes in currency exchange rates (primarily the euro) increased our net sales by approximately $42 million in the first six months of 2021 as compared to the first six months of 2020. TiO2 selling prices will increase or decrease generally as a result of competitive market pressures, changes in the relative level of supply and demand as well as changes in raw material and other manufacturing costs.
Our sales volumes increased 9% in the first six months of 2021 as compared to the first six months of 2020 primarily due to higher sales volumes in all major markets, with a significant portion of the increase occurring in the second quarter as a result of the impact of COVID-19 on the comparable period in 2020, as discussed above.
Cost of sales and gross margin - Cost of sales increased $115.8 million, or 19%, in the first six months of 2021 compared to the first six months of 2020 due to a 9% increase in sales volumes and higher production costs (including higher costs for raw materials and energy) and the effects of currency fluctuations (primarily the euro). Our cost of sales as a percentage of net sales increased to 78% in the first six months of 2021 compared to 77% in the same period of 2020 primarily due to the unfavorable effects of currency fluctuations, as discussed below.
Gross margin as a percentage of net sales decreased to 22% in the first six months of 2021 compared to 23% in the first six months of 2020. As discussed and quantified above, our gross margin as a percentage of net sales decreased primarily due to the net effects of higher sales volumes, higher raw materials and other production costs and fluctuations in currency exchange rates.
Selling, general and administrative expense - Selling, general and administrative expense was approximately 13% of net sales in the first six months of 2021 and 2020.
Income from operations - Income from operations increased by $1.3 million, or 2%, in the first six months of 2021 compared to the first six months of 2020. Income from operations as a percentage of net sales decreased to 8% in the first six months of 2021 from 9% in the same period of 2020. This decrease was driven by the lower gross margin discussed above. We estimate that changes in
- 20 -
currency exchange rates decreased income from operations by approximately $17 million in the first six months of 2021 as compared to the same period in 2020, as further discussed below.
Other non-operating income (expense) - We recognized a gain of $1.3 million on the change in value of our marketable equity securities in the first six months of 2021 and a loss of $1.7 million in the first six months of 2020. See Note 4 to our Condensed Consolidated Financial Statements. Other components of net periodic pension and OPEB cost in the first six months of 2021 decreased $.8 million compared to the first six months of 2020 primarily due to higher expected returns on plan assets offset by the net effects of lower discount rates impacting interest cost and previously unrecognized actuarial losses. See Note 9 to our Condensed Consolidated Financial Statements. We recognized an insurance settlement gain of $1.5 million related to a property damage claim recognized in the first six months of 2020. Interest expense in the first six months of 2021 increased $1.0 million compared to the first six months of 2020 due to the refinancing of our revolving credit facility in the second quarter of 2021 and the effects of changes in currency exchange rates.
Income tax expense - We recognized income tax expense of $15.2 million in the first six months of 2021 compared to income tax expense of $13.5 million in the first six months of 2020. The difference is primarily due to the jurisdictional mix of our earnings. Our earnings are subject to income tax in various U.S. and non-U.S. jurisdictions, and the income tax rates applicable to the pre-tax earnings (losses) of our non-U.S. operations are generally higher than the income tax rates applicable to our U.S. operations. We would generally expect our overall effective tax rate to be higher than the U.S. federal statutory tax rate of 21% primarily because of our sizeable non-U.S. operations. See Note 10 to our Condensed Consolidated Financial Statements.
Effects of currency exchange rates
We have substantial operations and assets located outside the United States (primarily in Germany, Belgium, Norway and Canada). The majority of our sales from non-U.S. operations are denominated in currencies other than the U.S. dollar, principally the euro, other major European currencies and the Canadian dollar. A portion of our sales generated from our non-U.S. operations is denominated in the U.S. dollar (and consequently our non-U.S. operations will generally hold U.S. dollars from time to time). Certain raw materials used in all our production facilities, primarily titanium-containing feedstocks, are purchased primarily in U.S. dollars, while labor and other production and administrative costs are incurred primarily in local currencies. Consequently, the translated U.S. dollar value of our non-U.S. sales and operating results are subject to currency exchange rate fluctuations which may favorably or unfavorably impact reported earnings and may affect the comparability of period-to-period operating results. In addition to the impact of the translation of sales and expenses over time, our non-U.S. operations also generate currency transaction gains and losses which primarily relate to (i) the difference between the currency exchange rates in effect when non-local currency sales or operating costs (primarily U.S. dollar denominated) are initially accrued and when such amounts are settled with the non-local currency, and (ii) changes in currency exchange rates during time periods when our non-U.S. operations are holding non-local currency (primarily U.S. dollars).
Overall, we estimate that fluctuations in currency exchange rates had the following effects on our sales and income from operations for the periods indicated.
|
Impact of changes in currency exchange rates Three months ended June 30, 2021 vs June 30, 2020 |
|
||||||||||||||||||
|
|
|||||||||||||||||||
|
|
|
|
|
Translation gains (losses) - impact of rate changes |
|
|
Total currency impact 2021 vs 2020 |
|
|||||||||||
|
|
Transaction gains (losses) recognized |
|
|
|
|
|
|||||||||||||
|
2020 |
|
|
2021 |
|
|
Change |
|||||||||||||
|
|
(In millions) |
|
|||||||||||||||||
|
Impact on: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
22 |
|
|
$ |
22 |
|
|
Income from operations |
|
(6 |
) |
|
|
1 |
|
|
|
7 |
|
|
|
(8 |
) |
|
|
(1 |
) |
The $22 million increase in net sales (translation gain) was caused primarily by a weakening of the U.S. dollar relative to the euro, as our euro-denominated sales were translated into more U.S. dollars in 2021 as compared to 2020. The weakening of the U.S. dollar relative to the Canadian dollar and the Norwegian krone in 2021 did not have a significant effect on our net sales, as a substantial portion of the sales generated by our Canadian and Norwegian operations is denominated in the U.S. dollar.
The $1 million decrease in income from operations was comprised of the following:
|
|
• |
Lower net currency transaction losses of approximately $7 million primarily caused by relative changes in currency exchange rates at each applicable balance sheet date between the U.S. dollar and the euro, Canadian dollar and the Norwegian krone, and between the euro and the Norwegian krone, which causes increases or decreases, as applicable, in |
- 21 -
|
|
U.S. dollar-denominated receivables and payables and U.S. dollar currency held by our non-U.S. operations, and in Norwegian krone denominated receivables and payables held by our non-U.S. operations, and |
|
|
• |
Approximately $8 million from net currency translation losses primarily caused by a weakening of the U.S. dollar relative to the Canadian dollar and the Norwegian krone, as local currency-denominated operating costs were translated into more U.S. dollars in 2021 as compared to 2020, partially offset by net currency translation gains primarily caused by a weakening of the U.S. dollar relative to the euro as the positive effects of the weaker U.S. dollar on euro-denominated sales more than offset the unfavorable effects of euro-denominated operating costs being translated into more U.S. dollars in 2021 as compared to 2020. |
|
Impact of changes in currency exchange rates Six months ended June 30, 2021 vs June 30, 2020 |
|
||||||||||||||||||
|
|
|||||||||||||||||||
|
|
|
|
|
Translation gains (losses) - impact of rate changes |
|
|
Total currency impact 2021 vs 2020 |
|
|||||||||||
|
|
Transaction gains recognized |
|
|
|
|
|
|||||||||||||
|
2020 |
|
|
2021 |
|
|
Change |
|||||||||||||
|
|
(In millions) |
|
|||||||||||||||||
|
Impact on: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
42 |
|
|
$ |
42 |
|
|
Income from operations |
|
6 |
|
|
|
- |
|
|
|
(6 |
) |
|
|
(11 |
) |
|
|
(17 |
) |
The $42 million increase in net sales (translation gain) was caused primarily by a weakening of the U.S. dollar relative to the euro, as our euro-denominated sales were translated into more U.S. dollars in 2021 as compared to 2020. The weakening of the U.S. dollar relative to the Canadian dollar and the Norwegian krone in 2021 did not have a significant effect on the reported amount of our net sales, as a substantial portion of the sales generated by our Canadian and Norwegian operations is denominated in the U.S. dollar.
The $17 million decrease in income from operations was comprised of the following:
|
|
• |
Lower net currency transaction gains of approximately $6 million primarily caused by relative changes in currency exchange rates at each applicable balance sheet date between the U.S. dollar and the euro, Canadian dollar and the Norwegian krone, and between the euro and the Norwegian krone, which causes increases or decreases, as applicable, in U.S. dollar-denominated receivables and payables and U.S. dollar currency held by our non-U.S. operations, and in Norwegian krone denominated receivables and payables held by our non-U.S. operations, and |
|
|
• |
Approximately $11 million from net currency translation losses primarily caused by a weakening of the U.S. dollar relative to the Canadian dollar and Norwegian krone, as local currency-denominated operating costs were translated into more U.S. dollars in 2021 as compared to 2020, partially offset by net currency translation gains primarily caused by a weakening of the U.S. dollar relative to the euro as the positive effects of the weaker U.S. dollar on euro-denominated sales more than offset the unfavorable effects of euro-denominated operating costs being translated into more U.S. dollars in 2021 as compared to 2020. |
Outlook
Beginning in the second half of 2020 and continuing through the first six months of 2021, our sales volumes have increased from reduced levels experienced in the first half of 2020 resulting from the COVID-19 pandemic. We increased production volumes in late 2020 to correspond to increasing demand and have continued to maintain these increased production volumes through the first six months of 2021. At the beginning of 2021, our average TiO2 selling prices were 3% lower than at the beginning of 2020 but average selling prices increased 4% during the first six months of 2021.
Based on current market conditions, we expect global demand for consumer products, including those of our customers, to remain strong throughout the remainder of 2021 and we expect that our sales and production volumes will reflect the elevated demand. As global economic activity continues to recover, we have experienced certain disruptions in global supply chains including availability of third-party feedstock and other raw materials along with transportation and logistics delays. Thus far our operations team has been able to manage through these disruptions with minimal impact on our operations; however, we expect these challenges to continue for the foreseeable future. In addition, we are experiencing increasing production costs, including higher raw material costs and related shipping costs and higher energy costs which are likely to continue through the end of the year. Driven by increased customer demand and rising costs, we expect sales prices for TiO2 will continue to rise throughout 2021, mitigating increases in distribution, raw materials and other production costs. As such, we expect our 2021 sales and income from operations will be higher than in 2020, principally due to higher TiO2 sales prices and higher sales volumes; however, we expect increasing costs to continue to challenge margins. We continue to monitor current and anticipated near-term customer demand levels and will align our production and inventories accordingly.
- 22 -
Our expectations for the TiO2 industry and our operations are based on a number of factors outside our control, including the ongoing economic effects of the COVID-19 pandemic. As noted above, we have experienced global supply chain disruptions, including disruptions related to COVID-19, and future impacts of COVID-19 on our operations will depend on, among other things, any future disruption in our operations or our suppliers’ operations and the timing and effectiveness of the global measures deployed to fight COVID-19 and its variants, all of which remain uncertain and cannot be predicted. Our manufacturing and administrative facilities are generally located in densely populated regions of Europe and North America which have experienced substantial outbreaks of COVID-19, some of which are in varying stages of recovery while others are experiencing a resurgence of outbreaks related to COVID-19 variants. We continue to employ a variety of methods to protect the health and well-being of our workforce and our customers and we have encouraged our employees to be vaccinated. To-date, we have had limited cases of COVID-19 among our workforce and all of our facilities have remained open and operational.
Liquidity and Capital Resources
Consolidated cash flows
Operating activities
Trends in cash flows as a result of our operating activities (excluding the impact of significant asset dispositions and relative changes in assets and liabilities) are generally similar to trends in our earnings. In addition to the impact of the operating, investing and financing cash flows discussed below, changes in the amount of cash, cash equivalents and restricted cash we report from period to period can be impacted by changes in currency exchange rates, since a portion of our cash, cash equivalents and restricted cash is held by our non-U.S. subsidiaries.
Cash provided by operating activities was $78.1 million in the first six months of 2021 compared to cash provided by operating activities of $18.1 million in the first six months of 2020. This $60.0 million increase in the amount of cash provided was primarily due to the net effect of the following:
|
|
• |
lower amount of net cash used associated with relative changes in our inventories, receivables, payables and accruals in 2021 of $92.5 million as compared to 2020, |
|
|
• |
higher income from operations in 2021 of $1.3 million, |
|
|
• |
higher cash paid for taxes in 2021 of $29.6 million due to the relative timing of payments (to provide COVID-19 related tax relief in 2020, certain tax payment deadlines were extended until the second half of 2020 in the U.S. and Norway), and |
|
|
• |
lower contributions to our TiO2 manufacturing joint venture in 2021 of $6.1 million. |
Changes in working capital were affected by accounts receivable and inventory changes. As shown below:
|
|
• |
Our average days sales outstanding, or DSO, decreased from December 31, 2020 to June 30, 2021 primarily due to relative changes in the timing of collections, and |
|
|
• |
Our average days sales in inventory, or DSI, decreased from December 31, 2020 to June 30, 2021 primarily due to lower inventory volumes attributable to higher sales volumes and timing of raw material shipments in the first six months of 2021 compared to 2020 while production volumes were comparable. |
For comparative purposes, we have also provided comparable prior year numbers below.
|
|
December 31, 2019 |
|
|
June 30, 2020 |
|
|
December 31, 2020 |
|
|
June 30, 2021 |
|
DSO |
71 days |
|
|
71 days |
|
|
68 days |
|
|
64 days |
|
DSI |
83 days |
|
|
85 days |
|
|
74 days |
|
|
53 days |
Investing activities
Our capital expenditures of $21.2 million and $25.4 million in the first six months of 2021 and 2020, respectively, were primarily to maintain and improve the cost effectiveness of our manufacturing facilities.
In addition, during the first six months of 2020, we received $1.5 million from an insurance settlement related to a property damage claim.
- 23 -
Financing activities
During the first six months of 2021 and 2020, we paid quarterly dividends of $.18 per share to stockholders aggregating $41.6 million.
In addition, during the first six months of 2020, we acquired 122,489 shares of our common stock in market transactions for an aggregate purchase price of $1.0 million.
Outstanding debt obligations
At June 30, 2021, our consolidated debt comprised:
|
|
• |
€400 million aggregate outstanding on our Kronos International, Inc. (KII) 3.75% Senior Secured Notes ($471.8 million carrying amount, net of unamortized debt issuance costs) due in September 2025 (Senior Secured Notes), and |
|
|
• |
approximately $1.4 million of other indebtedness. |
On April 20, 2021, we entered into a new $225 million global revolving credit facility (Global Revolver) which matures in April 2026. We have no outstanding borrowings on the new Global Revolver at June 30, 2021 and the full $225 million was available for borrowings thereunder. Our Senior Secured Notes and our new Global Revolver contain a number of covenants and restrictions which, among other things, restrict our ability to incur or guarantee additional debt, incur liens, pay dividends or make other restricted payments, or merge or consolidate with, or sell or transfer substantially all of our assets to, another entity, and contain other provisions and restrictive covenants customary in lending transactions of these types. Our credit agreements contain provisions which could result in the acceleration of indebtedness prior to their stated maturity for reasons other than defaults for failure to comply with typical financial or payment covenants. For example, the credit agreements allow the lender to accelerate the maturity of the indebtedness upon a change of control (as defined in the agreement) of the borrower. In addition, the credit agreements could result in the acceleration of all or a portion of the indebtedness following a sale of assets outside the ordinary course of business. The terms of all of our debt instruments outstanding at June 30, 2021 are discussed in Note 8 to our Consolidated Financial Statements included in our 2020 Annual Report. See Note 5 to our Condensed Consolidated Financial Statements for discussion of the terms of our new Global Revolver. We were in compliance with all of our debt covenants at June 30, 2021. We believe we will be able to maintain compliance with the financial covenants contained in our credit facility through its maturity.
Our assets consist primarily of investments in operating subsidiaries, and our ability to service our obligations, including the Senior Secured Notes, depends in part upon the distribution of earnings of our subsidiaries, whether in the form of dividends, advances or payments on account of intercompany obligations or otherwise. Our Senior Secured Notes are collateralized by, among other things, a first priority lien on (i) 100% of the common stock or other ownership interests of each existing and future direct domestic subsidiary of KII and the guarantors, and (ii) 65% of the voting common stock or other ownership interests and 100% of the non-voting common stock or other ownership interests of each non-U.S. subsidiary that is directly owned by KII or any guarantor. Our new Global Revolver is collateralized by, among other things, a first priority lien on the borrower’s trade receivables and inventories.
Future cash requirements
Liquidity
Our primary source of liquidity on an ongoing basis is cash flows from operating activities which is generally used to (i) fund capital expenditures, (ii) repay any short-term indebtedness incurred for working capital purposes and (iii) provide for the payment of dividends. From time-to-time we will incur indebtedness, generally to (i) fund short-term working capital needs, (ii) refinance existing indebtedness or (iii) fund major capital expenditures or the acquisition of other assets outside the ordinary course of business. We will also from time-to-time sell assets outside the ordinary course of business and use the proceeds to (i) repay existing indebtedness, (ii) make investments in marketable and other securities, (iii) fund major capital expenditures or the acquisition of other assets outside the ordinary course of business or (iv) pay dividends.
The TiO2 industry is cyclical, and changes in industry economic conditions significantly impact earnings and operating cash flows. Changes in TiO2 pricing, production volumes and customer demand, among other things, could significantly affect our liquidity.
- 24 -
We routinely evaluate our liquidity requirements, alternative uses of capital, capital needs and availability of resources in view of, among other things, our dividend policy, our debt service, our capital expenditure requirements and estimated future operating cash flows. As a result of this process, we have in the past and may in the future seek to reduce, refinance, repurchase or restructure indebtedness, raise additional capital, repurchase shares of our common stock, modify our dividend policy, restructure ownership interests, sell interests in our subsidiaries or other assets, or take a combination of these steps or other steps to manage our liquidity and capital resources. Such activities have in the past and may in the future involve related companies. In the normal course of our business, we may investigate, evaluate, discuss and engage in acquisition, joint venture, strategic relationship and other business combination opportunities in the TiO2 industry. In the event of any future acquisition or joint venture opportunity, we may consider using then-available liquidity, issuing our equity securities or incurring additional indebtedness.
At June 30, 2021 we had aggregate cash, cash equivalents and restricted cash on hand of $370.2 million, of which $122.2 million was held by non-U.S. subsidiaries. Following implementation of a territorial tax system under the 2017 Tax Act, repatriation of any cash and cash equivalents held by our non-U.S. subsidiaries would not be expected to result in any material income tax liability as a result of such repatriation. Our new $225 million Global Revolver we entered into in April 2021, which replaced our North American and European facilities, matures in April 2026 and currently, the full $225 million is available for borrowing under this facility and we could borrow all available amounts without violating our existing debt covenants. See Note 5 to our Condensed Consolidated Financial Statements. Based upon our expectation for the TiO2 industry and anticipated demands on cash resources, we expect to have sufficient liquidity to meet our short-term obligations (defined as the twelve-month period ending June 30, 2022) and our long-term obligations (defined as the five-year period ending June 30, 2026, our time period for long-term budgeting). If actual developments differ from our expectations, our liquidity could be adversely affected.
Capital expenditures
We intend to invest approximately $85 million in capital expenditures primarily to maintain and improve our existing facilities during 2021, including the $21.2 million we have spent through June 30, 2021. It is possible we will delay planned capital projects based on market conditions.
Stock repurchase program
At June 30, 2021, we have 1,563,519 shares available for repurchase under a stock repurchase program authorized by our board of directors.
Off-balance sheet financing
Neither we nor any of our subsidiaries or affiliates are parties to any off-balance sheet financing arrangements.
Commitments and contingencies
See Notes 10 and 12 to our Condensed Consolidated Financial Statements for a description of certain income tax contingencies, certain legal proceedings and other commitments.
Recent accounting pronouncements
Not applicable
Critical accounting policies
For a discussion of our critical accounting policies, refer to Part I, Item 7 - “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2020 Annual Report. There have been no changes in our critical accounting policies during the first six months of 2021.
|
ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK |
General
We are exposed to market risk, including currency exchange rates, interest rates, equity security and raw material prices. There have been no material changes in these market risks since we filed our 2020 Annual Report. See also Part I, Item 7A. - “Quantitative and Qualitative Disclosure About Market Risk” in our 2020 Annual Report and Note 13 to our Condensed Consolidated Financial Statements.
- 25 -
|
ITEM 4. |
CONTROLS AND PROCEDURES |
Evaluation of disclosure controls and procedures
We maintain disclosure controls and procedures which, as defined in Exchange Act Rule 13a-15(e), means controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit to the SEC under the Securities Exchange Act of 1934, as amended (the “Act”), is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information we are required to disclose in the reports we file or submit to the SEC under the Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions to be made regarding required disclosure. Each of Robert D. Graham, our Vice Chairman of the Board and Chief Executive Officer and Tim C. Hafer, our Senior Vice President and Chief Financial Officer, has evaluated the design and effectiveness of our disclosure controls and procedures as of June 30, 2021. Based upon their evaluation, these executive officers have concluded that our disclosure controls and procedures are effective as of the date of such evaluation.
Internal control over financial reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting which, as defined by Exchange Act Rule 13a-15(f) means a process designed by, or under the supervision of, our principal executive and principal financial officers, or persons performing similar functions, and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that:
|
|
• |
Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets, |
|
|
• |
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and |
|
|
• |
Provide reasonable assurance regarding prevention or timely detection of an unauthorized acquisition, use or disposition of our assets that could have a material effect on our Condensed Consolidated Financial Statements. |
Other
As permitted by the SEC, our assessment of internal control over financial reporting excludes (i) internal control over financial reporting of our equity method investees and (ii) internal control over the preparation of any financial statement schedules which would be required by Article 12 of Regulation S-X. However, our assessment of internal control over financial reporting with respect to our equity method investees did include our controls over the recording of amounts related to our investment that are recorded in our Condensed Consolidated Financial Statements, including controls over the selection of accounting methods for our investments, the recognition of equity method earnings and losses and the determination, valuation and recording of our investment account balances.
Changes in internal control over financial reporting
There has been no change to our internal control over financial reporting during the quarter ended June 30, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
- 26 -
Part II. OTHER INFORMATION
|
Item 1. |
Legal Proceedings |
Refer to Note 12 to our Condensed Consolidated Financial Statements and our 2020 Annual Report for descriptions of certain legal proceedings.
|
Item 1A. |
Risk Factors |
For a discussion of the risk factors related to our businesses, refer to Part I, Item 1A, “Risk Factors,” in our 2020 Annual Report.
|
Item 6. |
Exhibits |
|
31.1 |
|
|
|
|
|
|
|
31.2 |
|
|
|
|
|
|
|
32.1 |
|
|
|
|
|
|
|
101.INS |
|
Inline XBRL Instance - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
|
|
|
|
|
101.SCH |
|
Inline XBRL Taxonomy Extension Schema |
|
|
|
|
|
101.CAL |
|
Inline XBRL Taxonomy Extension Calculation Linkbase |
|
|
|
|
|
101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase |
|
|
|
|
|
101.LAB |
|
Inline XBRL Taxonomy Extension Label Linkbase |
|
|
|
|
|
101.PRE |
|
Inline XBRL Taxonomy Extension Presentation Linkbase |
|
|
|
|
|
104 |
|
Cover page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
|
|
||
- 27 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
Kronos Worldwide, Inc. |
|
|
|
(Registrant) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Date: August 4, 2021 |
|
/s/ Tim C. Hafer |
|
|
|
Tim C. Hafer |
|
|
|
Senior Vice President and Chief Financial Officer (duly authorized officer) |
|
|
|
|
- 28 -
Exhibit 31.1
CERTIFICATION
I, Robert D. Graham, certify that:
|
1) |
I have reviewed this quarterly report on Form 10-Q of Kronos Worldwide, Inc.; |
|
2) |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3) |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4) |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5) |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: August 4, 2021
|
|
|
|
|
/s/ Robert D. Graham |
|
Robert D. Graham |
|
Chief Executive Officer |
Exhibit 31.2
CERTIFICATION
I, Tim C. Hafer, certify that:
|
1) |
I have reviewed this quarterly report on Form 10-Q of Kronos Worldwide, Inc.; |
|
2) |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3) |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4) |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5) |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: August 4, 2021
|
|
|
|
|
/s/ Tim C. Hafer |
|
Tim C. Hafer |
|
Chief Financial Officer |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Kronos Worldwide, Inc. (the Company) on Form 10-Q for the quarter ended June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Robert D. Graham, Chief Executive Officer of the Company, and I, Tim C. Hafer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
|
|
|
|
/s/ Robert D. Graham |
|
Robert D. Graham |
|
Chief Executive Officer |
|
|
|
|
|
/s/ Tim C. Hafer |
|
Tim C. Hafer |
|
Chief Financial Officer |
August 4, 2021
Note: The certification the registrant furnishes in this exhibit is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. Registration Statements or other documents filed with the Securities and Exchange Commission shall not incorporate this exhibit by reference, except as otherwise expressly stated in such filing.